1. WHO Global Vaccine Safety Blueprint 2.0 (GVSB2.0) Draft 1 for public consultation available at https://www.who.int/vaccine_safety/gvs_blueprint-consultation/en/.
2. A Change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States;Gambhir;PLoS Comput Biol,2015
3. Vaccine effects and impact of vaccination programmes in post-licensure studies;Hanquet;Vaccine,2012
4. WHO Global Vaccine Safety Initiative, Meeting report 2017. Accessible at https://apps.who.int/iris/bitstream/handle/10665/260409/WHO-EMP-SAV-2018.2-eng.pdf;jsessionid=676193083CB73B0C3E682E5A1851C061?sequence=1.
5. CIOMS/WHO. Definition and Application of Terms for Vaccine Pharmacovigilance. Report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance, Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS); 2012. Accessible at https://vaccine-safety-training.org/tl_files/vs/pdf/report-of-cioms-who-working-group.pdf.